Aceto Corporation is a specialty chemical company that develops, manufactures and distributes active pharmaceutical ingredients (APIs), research chemicals and fine‐chemicals to customers in the life sciences, pharmaceutical and biotechnology industries. Through its Pharmaceutical Technologies segment, Aceto offers a broad array of branded and generic APIs, finished dosage forms, and particle engineered compounds designed to support drug development and commercial manufacturing. The Diversified Chemicals segment supplies industrial and research institutions with custom and catalog chemical offerings, including advanced intermediates, solvents, reagents and specialty materials for laboratory and production use.
Aceto’s product portfolio encompasses custom synthesis and contract development services, supporting each stage of the drug discovery and development process. The company’s technical staff collaborates with customers on formulation optimization, analytical method development and regulatory submissions. With capabilities in kilo‐lab through multi‐ton scale manufacturing, Aceto provides integrated solutions that address complex purity, particle size and delivery requirements for small-molecule therapies and specialty ingredients.
Founded in 1921, Aceto is headquartered in Long Island City, New York, and operates a network of manufacturing and distribution facilities across North America, Europe and Asia. Over its century‐long history, the company has expanded its global footprint through strategic partnerships and facility investments to serve customers in more than 80 countries. Aceto maintains a leadership team with deep experience in chemistry, operations and regulatory affairs, reflecting its commitment to quality, compliance and innovation in support of emerging and established life sciences customers.
AI Generated. May Contain Errors.
Free ACETQ Stock Alerts